Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Open in API
Filings indexed 715 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Intimation of Q4 & FY 2026 Earnings Call.
Regulatory Filings Classification · 85% confidence The document is an announcement to stock exchanges under SEBI Listing Regulations informing investors of an upcoming earnings conference call for Q4 & FY26. It contains no financial data or results, nor a conference call transcript or presentation materials—just logistical details. It is a general regulatory announcement/fallback filing under Reg.30, so it falls under Regulatory Filings (RNS).
2026-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is an exchange filing under SEBI Listing Regulations providing notice of an earnings conference call (date, time, dial-in details) but contains no financial data, results or transcript. It is not the earnings release itself nor a full report or transcript. It is a regulatory disclosure/announcement, so it falls under the general Regulatory Filings category (RNS).
2026-05-20 English
Hikal Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Audited Financial Results (Standalone ....
Regulatory Filings Classification · 85% confidence The document is a formal notice to stock exchanges under SEBI Listing Regulations (Regulation 29) announcing a Board Meeting date. It does not present financial results or actual data, nor does it announce management changes. It is a compliance/regulatory announcement falling under general regulatory filings.
2026-05-20 English
Retirement
Board/Management Information Classification · 100% confidence The document is a formal disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, announcing a change in senior management personnel. It specifically informs about the superannuation and cessation of Mr. Vimaldeep Kulshrestha as President - Crop Protection. The document includes details required by SEBI regulations for such disclosures. There are no financial statements, earnings data, or other report contents. The document is a regulatory announcement about management change, fitting the category of Board/Management Information (MANG). The document length is 2849 characters, which is short and consistent with a management change announcement rather than a full report.
2026-04-14 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter from the company to the National Stock Exchange of India addressing a regulatory query about a discrepancy in the Earnings Per Share (EPS) disclosure in the XBRL financial results filing. It clarifies an inadvertent error in the EPS classification and provides corrected figures. The document is short (1774 characters) and serves as a regulatory response or clarification rather than a full financial report or earnings release. It does not contain comprehensive financial data or detailed results but is a compliance communication to a regulatory body. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-04-13 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement about a special window for transfer and dematerialisation of physical securities and a campaign for updating KYC details and claiming unpaid/unclaimed dividends. It references SEBI circulars and investor education fund authority letters. The content is primarily an announcement of a shareholder-related campaign and advertisement, not a financial report or detailed regulatory filing. The document length is about 15,000 characters, but the content is an announcement of an event or campaign rather than a report or detailed financial data. It does not contain financial statements, audit opinions, management discussions, or earnings data. It is not a proxy solicitation, voting results, or board change announcement. It is also not a dividend amount notice, but relates to shareholder services and compliance. Given the nature of the content, it best fits under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-04-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.